Embolization Particle Market

Embolization Particle Market Research, 2032

[170+ Pages Research Report] to surpass USD 8 billion by 2032 from USD 2.13 billion in 2021 at a CAGR of 12.7% throughout the forecast period 2022-32.

Embolization is a minimal invasive procedure where an embolus is injected to cease bleeding or to terminate blood supply to tumor for it to shrink in order to remove. Embolization is helpful in radiology procedures, to treat hemorrhages, several cancerous tumors & management of malignant. For this process, interventional radiologist uses image guidance to insert the catheter into blood vessel to terminate blood supply. Embolization is an alternative for tumors patients where surgery can’t be performed. It can be used for tumors that are generally greater than 5 cm thickness & cannot be separated by ablation. This procedure involves the initiation of emboli for occluding the blood vessels selectively.

Market Highlights

Embolization Particle market is expected to project a CAGR of 12.7% during the forecast period

Embolization Particle market is expected to exceed beyond USD 8.0 billion by 2032 from USD 2.13 billion in 2021, growing at a CAGR of 12.7% during the forecast period, 2022-2032. Embolization particles are vital ingredients used to treat malignancies and the rising prevalence of cancer has aided in the growth of the embolization particle market. The increasing burden of cancer in several countries is expected to boost the growth of the market. The increasing expenditure of government to improve the pharmaceutical Research & Development is estimated to boost the growth of the Embolization Particle market.

Figure - Market Analysis of Embolization Particle Market

Embolization Particle Market: Segments

Peripheral Vascular Disease segment is expected to grow with a higher CAGR during 2022-32

Embolization Particle market is classified based on Application into Oncology, Peripheral Vascular Disease, Urology, Neurology, Others. Peripheral Vascular Disease segment dominated the market in 2021 and is also expected to dominate in the forecast period owing to the rising prevalence of cancers and strong expansion of the oncology sector which is expected to drive the market growth in the forecast period. Embolization Particles are the key products used in malignancies treatment and the increasing awareness about embolization procedures is expected to boost the growth of Embolization Particle market.

Radioembolization Spheres segment is expected to grow with a higher CAGR during 2022-32

Embolization Particle market is classified based on the Product Type into Radioembolization Spheres, Drug Eluting Beads, Microspheres, PVA Particles & Gelfoam Particles, Others. Radioembolization Spheres segment is expected to dominate the Embolization Particle market as the embolization Particles are used in the treatment of cancer which are of major importance in the growth of the market.

Figure - Embolization Particle Market Segment Analysis

Market Dynamics                                                

Growth Drivers

Rising Occurrence of Cancer is Expected to Boost the Growth of the Market

The occurrence of cancers like prostrate, liver, bowel, breast, lung cancers has increased and the necessity of embolization particles has raised which created a growth opportunity for the market. The people being affected with various types of cancers is increasing and the proliferation of cancerous cells is rising which is creating demand for the growth of the Embolization Particle market.

Increasing Advancements in Technology is Expected to Drive the Market Growth

The key market players are focusing on implementing advancements in technology to innovate various novel products which has a scope of improvement and increased efficiency that will assist in the growth of the market. New therapies are emerging as an alternative option to the traditional therapies and are expected to boost the growth of the Embolization Particle market.

Restraint

Stringent Regulations for Approval of Embolization Particles is Expected to Restrain the Market Growth

The Embolization Particle Market expansion would be hindered due to the presence of a smaller number of labs related to interventional neuroradiologists and neuroradiology (INR). The stringent regulations for the approval of embolization particle may also restrain the growth of the global embolization particle market. The deficiency of presence of skilled professionals may hamper the growth of the global embolization particle market.

Recent Developments

• In November 2018, Boston Scientific declared that it plans to acquire BTG plc for developing and commercializing products used in minimally-invasive procedures targeting cancer.
• In 2017, Sirtex launched SIR-Spheres Y-90 resin microspheres, which is a first-line treatment for liver metastases patients from right-sided primary colon cancer.

Embolization Particle Market:Key Players

• Merit Medical

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

• Boston Scientific Corporation
• Pfizer
• Edward Lifesciences
• Sirtex Medical
• HENGRUI Medical
• Cook Medical
• Johnson & Johnson
• BTG Medical
• Terumo Corporation
• Interface Biomaterials B.V. 
• Abbott Laboratories
• Other Prominent Players

Embolization Particle Market: Regions

Embolization Particle market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominated the market with the largest share in 2021 owing to the large expansion of healthcare system, the presence of strong economic condition in the region and rising focus on modernizing of the technology by research institutions. The Asia Pacific market is expected to dominate the Embolization Particle market in the forecast period owing to the availability of skilled healthcare professionals, rising patient population, increasing medical tourism and increasing government initiatives for enhancing healthcare facilities which is expected to boost the growth of the market in this region.

Embolization Particle Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Embolization Particle Market report also contains analysis on:

Embolization Particle Market Segments:

• By Product Type 
  • Radioembolization Spheres
  • Drug Eluting Beads
  • Microspheres
  • PVA Particles & Gelfoam Particles
  • Others
• By Application
  • Oncology
  • Peripheral Vascular Disease
  • Urology
  • Neurology
  • Others
• By End User
  • Ambulatory Centers
  • Hospitals
  • Clinics 
• Embolization Particle Market Dynamics
• Embolization Particle Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Embolization Particle Market Report Scope and Segmentation

Frequently Asked Questions (FAQ):